Alageel, Asem A.
Alyahya, Rayyan A.
A. Bahatheq, Yasser
Alzunaydi, Norah A.
Alghamdi, Raed A.
Alrahili, Nader M
McIntyre, Roger S.
Iacobucci, Michelle
Article History
Received: 24 December 2020
Accepted: 13 May 2021
First Online: 10 June 2021
Declarations
:
: In accordance with the WMA Declaration of Helsinki guidelines and the Vancouver protocol, this study was approved by the IRB of IMSIU in Riyadh, Saudi Arabia.Informed consent was obtained from all participants through a statement of agreement at the beginning of each questionnaire. Protection of the privacy of research subjects as well as confidentiality of their personal information was ensured. Each subject was adequately informed of the aims, methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the study, the discomfort it may entail, post-study provisions, and all other relevant aspects of the study, in accordance with the WMA Declaration of Helsinki guidelines and the Vancouver protocol.
: Not applicable.
: Dr. McIntyre reports grants from Stanley Medical Research Institute, and from CIHR/GACD/Chinese National Natural Research Foundation, as well as relationships from Lundbeck, Janssen, Shire, Purdue, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, and Minerva, which may include consultations or speaker fees outside of the submitted work.All other authors declare no conflicts of interest.